News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CYTOO SA: ReferenceCell Platform for Improved High Content Screening will be Assessed by Leading Industry Consortium


4/27/2011 8:34:44 AM

NEEDHAM, Mass. & GRENOBLE, France--(BUSINESS WIRE)--The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with CYTOO, a provider of innovative products for the life science research and drug discovery markets with an emphasis in cell based assays, high content analysis and cell screening, today announced a new program as part of DSEC’s Technology Evaluation Consortium.

Read at BioSpace.com


comments powered by Disqus
Cytoo
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES